SPIA
SLDB icon

Steward Partners Investment Advisory’s Solid Biosciences SLDB Stock Holding History

Steward Partners Investment Advisory’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.5K Hold
4,955
– – ﹤0.01% 2950
2026
Q1 		$35.7K Hold
4,955
– – ﹤0.01% 2949
2025
Q4 		$27.9K Hold
4,955
– – ﹤0.01% 2985
2025
Q3 		$30.6K Hold
4,955
– – ﹤0.01% 2881
2025
Q2 		$24.1K Hold
4,955
– – ﹤0.01% 2830
2025
Q1 		$18.3K Hold
4,955
– – ﹤0.01% 2850
2024
Q4 		$19.8K Buy
4,955
+1,000
+25% +$5.49K ﹤0.01% 2804
2024
Q3 		$27.6K Buy
+3,955
New +$32.1K ﹤0.01% 2512

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Steward Partners Investment Advisory's SLDB Position: Q2 2026 in Review

Steward Partners Investment Advisory held its Solid Biosciences (SLDB) position steady in Q2 2026 at 4,955 shares worth $49.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2950.

Steward Partners Investment Advisory first reported a position in SLDB in Q3 2024 and has held it in 8 quarters since. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • Steward Partners Investment Advisory held 4,955 shares of Solid Biosciences worth $49.5K as of Q2 2026.
  • Steward Partners Investment Advisory left its Solid Biosciences share count unchanged in Q2 2026.
  • Solid Biosciences made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #2950 holding.
  • Steward Partners Investment Advisory first reported a position in Solid Biosciences in Q3 2024 and has held it in 8 quarters since.
  • 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.